ATE334984T1 - N,n'-verbrückte, n-substituierte carbacyclische indolcarbazole als protein-kinase hemmer - Google Patents

N,n'-verbrückte, n-substituierte carbacyclische indolcarbazole als protein-kinase hemmer

Info

Publication number
ATE334984T1
ATE334984T1 AT03780067T AT03780067T ATE334984T1 AT E334984 T1 ATE334984 T1 AT E334984T1 AT 03780067 T AT03780067 T AT 03780067T AT 03780067 T AT03780067 T AT 03780067T AT E334984 T1 ATE334984 T1 AT E334984T1
Authority
AT
Austria
Prior art keywords
protein kinase
kinase inhibitors
indolecarbazoles
bridged
same
Prior art date
Application number
AT03780067T
Other languages
English (en)
Inventor
Barbara Monse
Tobias Braxmeier
Sandrine Ferrand
Sandra Gordon
Hans Klafki
Gezim Lahu
Hanno Roder
Heidi Sahagun-Krause
Pierfausto Seneci
Du Boullay Olivier Thillaye
Original Assignee
Nad Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nad Ag filed Critical Nad Ag
Application granted granted Critical
Publication of ATE334984T1 publication Critical patent/ATE334984T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Enzymes And Modification Thereof (AREA)
AT03780067T 2002-11-27 2003-11-26 N,n'-verbrückte, n-substituierte carbacyclische indolcarbazole als protein-kinase hemmer ATE334984T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10255343A DE10255343B4 (de) 2002-11-27 2002-11-27 N,N-Verbrückte, Stickstoff-Substituierte Carbacyclische Indolocarbazole als Proteinkinase-Inhibitoren

Publications (1)

Publication Number Publication Date
ATE334984T1 true ATE334984T1 (de) 2006-08-15

Family

ID=32318728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03780067T ATE334984T1 (de) 2002-11-27 2003-11-26 N,n'-verbrückte, n-substituierte carbacyclische indolcarbazole als protein-kinase hemmer

Country Status (8)

Country Link
US (1) US20070149481A1 (de)
EP (1) EP1565473B1 (de)
JP (1) JP2006517519A (de)
AT (1) ATE334984T1 (de)
AU (1) AU2003288180A1 (de)
CA (1) CA2502200A1 (de)
DE (2) DE10255343B4 (de)
WO (1) WO2004048384A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517882B2 (en) 2006-09-18 2009-04-14 Polaris Group Protein kinase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840442A (en) * 1972-04-07 1974-10-08 J Moisan Titanium or titanium alloys having an anodized surface layer and method of forming
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
US6013646A (en) * 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer

Also Published As

Publication number Publication date
CA2502200A1 (en) 2004-06-10
AU2003288180A1 (en) 2004-06-18
DE60307316D1 (de) 2006-09-14
JP2006517519A (ja) 2006-07-27
WO2004048384A1 (en) 2004-06-10
DE10255343A1 (de) 2004-06-17
DE60307316T2 (de) 2008-01-10
EP1565473A1 (de) 2005-08-24
EP1565473B1 (de) 2006-08-02
US20070149481A1 (en) 2007-06-28
DE10255343B4 (de) 2006-09-07

Similar Documents

Publication Publication Date Title
DE602005024004D1 (de) Als beta-sekretase (bace)-hemmer nützliche 2-amino-chinazolinderivate
ATE482936T1 (de) Als b-sekretase (bace)-hemmer nützliche 2-amino- chinazolinderivate
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
TW200634012A (en) 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
ATE532781T1 (de) 5-(acylamino)indazol-derivate als kinase- inhibitoren
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
YU66101A (sh) Nova jedinjenja i kompozicije kao inhibitori proteaze
DE60316013D1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
EA200400648A1 (ru) N, n'-замещенные производные 1,3-диамино-2-гидроксипропана
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
ATE284690T1 (de) Antithrombotische diamine
EA200500299A1 (ru) Пиразольные композиции, используемые в качестве ингибиторов gsk-3
TW200504067A (en) New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
MX2007004841A (es) Triazoles utiles como inhibidores de proteinas cinasas.
EP1689713A4 (de) Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
SE0403171D0 (sv) New compounds
WO2006055434A3 (en) Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1565473

Country of ref document: EP

REN Ceased due to non-payment of the annual fee